652 related articles for article (PubMed ID: 28951820)
1. Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.
Chen C; Cohrs CM; Stertmann J; Bozsak R; Speier S
Mol Metab; 2017 Sep; 6(9):943-957. PubMed ID: 28951820
[TBL] [Abstract][Full Text] [Related]
2. Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas.
Tritschler S; Theis FJ; Lickert H; Böttcher A
Mol Metab; 2017 Sep; 6(9):974-990. PubMed ID: 28951822
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
4. Modelling the endocrine pancreas in health and disease.
Bakhti M; Böttcher A; Lickert H
Nat Rev Endocrinol; 2019 Mar; 15(3):155-171. PubMed ID: 30504925
[TBL] [Abstract][Full Text] [Related]
5. The Eye as a Transplantation Site to Monitor Pancreatic Islet Cell Plasticity.
Ilegems E; Berggren PO
Front Endocrinol (Lausanne); 2021; 12():652853. PubMed ID: 33967961
[TBL] [Abstract][Full Text] [Related]
6. Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.
Miki A; Ricordi C; Sakuma Y; Yamamoto T; Misawa R; Mita A; Molano RD; Vaziri ND; Pileggi A; Ichii H
PLoS One; 2018; 13(5):e0196570. PubMed ID: 29723228
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies.
Costes S; Bertrand G; Ravier MA
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069914
[TBL] [Abstract][Full Text] [Related]
9. The effects of beta-cell mass and function, intercellular coupling, and islet synchrony on [Formula: see text] dynamics.
Saadati M; Jamali Y
Sci Rep; 2021 May; 11(1):10268. PubMed ID: 33986325
[TBL] [Abstract][Full Text] [Related]
10. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
[TBL] [Abstract][Full Text] [Related]
11. The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus.
Gerber PA; Rutter GA
Antioxid Redox Signal; 2017 Apr; 26(10):501-518. PubMed ID: 27225690
[TBL] [Abstract][Full Text] [Related]
12. Restoring a functional beta-cell mass in diabetes.
Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
[TBL] [Abstract][Full Text] [Related]
13. How to make insulin-producing pancreatic β cells for diabetes treatment.
Lu J; Xia Q; Zhou Q
Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
[TBL] [Abstract][Full Text] [Related]
14. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes.
Triolo TM; Bellin MD
Front Endocrinol (Lausanne); 2021; 12():636824. PubMed ID: 33776933
[TBL] [Abstract][Full Text] [Related]
15. Intraocular
Leibiger IB; Berggren PO
Mol Metab; 2017 Sep; 6(9):1002-1009. PubMed ID: 28951824
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in
Kang T; Boland BB; Jensen P; Alarcon C; Nawrocki A; Grimsby JS; Rhodes CJ; Larsen MR
Mol Cell Proteomics; 2020 Jun; 19(6):971-993. PubMed ID: 32265294
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles of β-cell mass and function during type 1 diabetes onset and remission.
Chmelova H; Cohrs CM; Chouinard JA; Petzold C; Kuhn M; Chen C; Roeder I; Kretschmer K; Speier S
Diabetes; 2015 Jun; 64(6):2148-60. PubMed ID: 25605805
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of Persisting β Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis.
Cohrs CM; Panzer JK; Drotar DM; Enos SJ; Kipke N; Chen C; Bozsak R; Schöniger E; Ehehalt F; Distler M; Brennand A; Bornstein SR; Weitz J; Solimena M; Speier S
Cell Rep; 2020 Apr; 31(1):107469. PubMed ID: 32268101
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed beta cell CART increases insulin secretion in mouse models of insulin resistance and diabetes.
Abels M; Riva M; Shcherbina L; Fischer AT; Banke E; Degerman E; Lindqvist A; Wierup N
Peptides; 2022 May; 151():170747. PubMed ID: 35065097
[TBL] [Abstract][Full Text] [Related]
20. Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes.
Zeynaloo E; Stone LD; Dikici E; Ricordi C; Deo SK; Bachas LG; Daunert S; Lanzoni G
Mol Aspects Med; 2022 Feb; 83():101063. PubMed ID: 34961627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
